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Adhesion to target cells is disrupted by the killer cell
inhibitory receptor
Deborah N. Burshtyn*, Jiyeon Shin, Christopher Stebbins and Eric O. Long
Killer cell immunoglobulin-like receptors (KIR) inhibit
the cytotoxic activity of natural killer (NK) cells by
recruitment of the tyrosine phosphatase SHP-1 to
immunoreceptor tyrosine-based inhibition motif (ITIM)
sequences in the KIR cytoplasmic tail [1]. The precise
steps in the NK activation pathway that are inhibited by
KIR are yet to be defined. Here, we have studied
whether the initial step of adhesion molecule LFA-1-
dependent adhesion to target cells was altered by the
inhibitory signal. Using stable expression of an HLA-C-
specific KIR in the NK cell line YTS [2] and a two-color
flow cytometry assay for conjugate formation, we show
that adhesion to a target cell expressing cognate HLA-C
was disrupted by KIR engagement. Conjugate
formation was abruptly interrupted by KIR within less
than 5 minutes. Inhibition of adhesion to target cells
was mediated by a chimeric KIR molecule carrying
catalytically active SHP-1 in place of its cytoplasmic tail.
These results suggest that other ITIM-bearing
receptors, many of which have no known function, may
regulate adhesion in a wide variety of cell types. 
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Results and discussion
The NK cell line YTS stably expressing KIR2DL1 [2], an
inhibitory KIR specific for the major histocompatibility
complex antigen HLA-Cw4, was used to study the effect
of ligation of KIR on the formation of conjugates between
effector (NK) cells and target cells. As expected,
KIR2DL1 in YTS cells (YTS-2DL1) completely blocked
cytolysis of the transfected target cell 721.221 expressing
HLA-Cw4 (221-Cw4) but not that of the 721.221 transfec-
tant expressing HLA-Cw3 (221-Cw3) (see Supplementary
material), an allotype that is not recognized by KIR2DL1
[3,4]. Effector–target cell heteroconjugates were analyzed
by two-color flow cytometry (Figure 1). Binding equilib-
rium was reached by 10 min at 37°C with ~80% of YTS
cells bound to target cells (Figure 2a). Within less than
5 min, however, KIR2DL1 disrupted conjugate formation
with 221-Cw4 cells such that the number of effector cells
in conjugates was reduced to 20–30% (Figure 2a). Conju-
gate formation of YTS-2DL1 with 221-Cw3 cells was not
affected. Similar results were obtained using another pair
of target cells expressing HLA-C molecules that are either
recognized by KIR2DL1 (HLA-Cw15) or not (HLA-Cw8)
(see Supplementary material). Binding of the KIR2DL1-
specific immunoglobulin M (IgM) monoclonal antibody
HP-3E4 to YTS-2DL1 restored the number of conjugates
with 221-Cw4 to a level similar to that obtained with 221-
Cw3, implying that the inhibition observed was due to
KIR2DL1 (Figure 2b).
To test whether the tyrosine phosphatase SHP-1 may be
involved in inhibition of adhesion, chimeric molecules con-
sisting of KIR2DL1 in which the ITIMs in the cytoplasmic
tail had been replaced by full-length SHP-1 were trans-
fected into YTS. This 2DL1–SHP-1 construct blocked
conjugate formation with 221-Cw4 cells as effectively as
the intact receptor (Figure 2c). A small decrease in conju-
gate formation was observed with a mutated SHP-1 that
has greatly reduced substrate binding and catalytic activity
(2DL1–SHP-1(RM), Figure 2c). The two chimeric
KIR–SHP-1 molecules had no effect on adhesion to 221-
Cw3 cells. These experiments show that SHP-1 is able to
inhibit adhesion and, further, that a functional catalytic
Figure 1
Formation of YTS–target cell conjugates. Typical flow cytometric data
for binding of YTS NK cells to 221-Cw3 target cells after (a) 0 min and
(b) 10 min of incubation at 37°C. Green fluorescence on the x axis
detects NK cells; red fluorescence on the y axis detects target cells.
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domain of SHP-1 is required for this inhibition. In
support of this conclusion, a mutant KIR2DL1 with a
truncated cytoplasmic tail lacking both ITIMs did not
inhibit adhesion to 221-Cw4 cells (D.N.B., M. Peterson,
M. Sandusky and E.O.L., unpublished observations. It is
still possible that something other than SHP-1 is also
recruited by KIR to inhibit adhesion.
The requirements for adhesion of YTS cells to 721.221
cells were evaluated by varying the temperature of the
assay and by the addition of blocking antibodies to LFA-1.
Adhesion was temperature-dependent, with a noticeable
decrease observed at 17°C, and no binding at 4°C (see Sup-
plementary material). Formation of conjugates was blocked
by anti-LFA-1 antibodies (Figure 3a), as was the killing of
721.221 cells (Figure 3d). The dependence on temperature
and on LFA-1 suggests that adhesion of YTS to target cells
uses the ‘inside-out’ signal through LFA-1 [5]. High-affin-
ity or -avidity LFA-1-mediated binding of T cells to
ICAM-1, a ligand of LFA-1, requires an inside-out signal
that can be provided by aggregation of the costimulatory
molecule CD28 [6], a molecule that is expressed by YTS
cells. The cell line YT2C2, another subclone of YT, killed
mouse target cells when these mouse cells had been trans-
fected with human B7 (the ligand of CD28) and ICAM-1
[7]. To test whether CD28 contributed to adhesion and
killing by YTS cells, we performed antibody blocking
experiments. Adhesion was only reduced partially by anti-
CD28 antibody (Figure 3a), even though cytolysis was
completely abolished (Figure 3d). Therefore, CD28 con-
tributes a critical signal for cytolysis but may be dispens-
able for LFA-1-mediated adhesion. However, it is also
possible that antibody binding to CD28 induced a signal for
adhesion but not for cytolysis. To address this possibility
we masked B7 on target cells with soluble CTLA-4–Ig
fusion protein. Conjugate formation was reduced by 50% at
8 mg/ml CTLA-4–Ig whereas target cell lysis was reduced
by half at only 1 mg/ml of CTLA-4–Ig (Figure 3b,e). This
result is similar to that of another study in which killing of a
B-cell line by YT cells was also reduced by half at 1 mg/ml
of CTLA-4–Ig [8]. These results demonstrate the impor-
tance of CD28 in activation of cytolysis. They also suggest
that CD28 (or the putative NK-specific receptor for B7 [9])
may contribute to adhesion. Although it is clear that lysis of
721.221 cells by YTS is tightly regulated by a signal from
CD28, adhesion may be induced by signals coming from
other activation receptors.
Given that KIR recruits and activates the tyrosine phos-
phatase SHP-1 and that a KIR–SHP-1 chimera inhibits
adhesion (Figure 2c), it is likely that the target of KIR
inhibition includes signaling pathways mediated by tyro-
sine kinases. A specific inhibitor of Src family kinases,
PP1, inhibited both conjugate formation with, and lysis of
sensitive target cells (Figure 3c,f). The reduced conjugate
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Figure 2
(a) Conjugate formation was measured at 37°C for YTS (circles)
and YTS-2DL1 (squares) cells with 221-Cw3 (open symbols) and
221-Cw4 cells (filled symbols) cells. (b) Conjugate formation of
YTS-2DL1 with 221-Cw3 and 221-Cw4 was measured after 10 min
at 37°C in the presence of a control IgM MOPC104E (gray bars) or
anti-KIR2DL1 IgM antibody HP-3E4 (white bars). (c) Conjugates were
measured as in (a) using YTS lines expressing the chimeric receptors
2DL1–SHP-1 (circles) or 2DL1–SHP-1(RM) (triangles).
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Figure 3
Requirements for adhesion and cytolysis by YTS-2DL1.
(a–c) Conjugate formation and (d–f) target cell lysis by YTS-2DL1
were measured with 221-Cw3 (open symbols) or 221-Cw4 cells (filled
symbols). (a,d) The assays were carried out in the presence of
MOPC21 (control) IgG (circles), anti-LFA-1 (triangles), or anti-CD28
(squares) antibodies. Antibody concentration in (a) was 10 mg/ml.
(b,e) Assays were carried out in the presence of MOPC21 IgG
(circles) and CTLA-4–Ig (squares). (c,f) YTS-2DL1 cells were
pretreated with PP1 at 0 mM (circles), 2 mM (triangles), 4 mM (squares)
and 8 mM (diamonds). PP1 was included in the lysis assay.
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formation with 221-Cw4 cells due to inhibition by KIR
was not reduced further by PP1 (Figure 3c). However, the
blocking anti-KIR2DL1 monoclonal antibody HP-3E4
eliminated this PP1-resistant adhesion to 221-Cw4 cells
(see Supplementary material), indicating that the interac-
tion of KIR2DL1 with HLA-Cw4 on target cells itself
contributes some level of adhesion. Our data show that
KIR interferes with the ability of NK cells to form conju-
gates with target cells, despite its own ability to provide
some adhesion. Inhibition of adhesion and of cytotoxicity
by KIR may be achieved by SHP-1-mediated dephospho-
rylation of a substrate produced at a proximal step in the
activation pathway that lies upstream of signals for adhe-
sion and cytotoxicity. Alternatively, KIR may be able to
inhibit signals generated by different receptors, one
leading to adhesion and another to target cell killing.
We have established that KIR engagement disrupts con-
jugation of YTS cells with target cells that bear the appro-
priate MHC class I molecule. In an earlier study,
IL-2-activated human NK clones formed conjugates with
target cells to the same extent whether the targets were
sensitive or resistant to killing on the basis of MHC class I
expression [10]. However, the fraction of NK cells that
formed conjugates was about 15%, which is considerably
lower than the fraction reported here with the YTS cell
line. In agreement with our results, a recent study using
live videomicroscopy reported that mouse NK cells spent,
on average, less time in conjugates with resistant target
cells than with sensitive target cells despite a large vari-
ability in the duration of individual conjugates [11]. The
concentric distribution of KIR around a core of LFA-1 at
the NK–target cell interface [12] may relate to the ability
of KIR to disrupt adhesion. Such disruption of NK cell
conjugation with resistant target cells may serve the
useful purpose of increasing the availabilty of NK cells for
the detection of sensitive cells that will elicit a cytotoxic
NK response.
An important implication of the new KIR function
reported here is that other ITIM-bearing receptors may
also serve to regulate cell adhesion, as already proposed
[13]. In fact, macrophages from SHP-1-defective motheaten
mice displayed an increase in adhesion mediated by the
aMb2 integrin [14]. The ITIM-containing receptors
SHPS-1 and PIR-B bind SHP-1 and SHP-2 in adherent
macrophages and may well provide signals that regulate
adhesion [13]. In addition, SHPS-1 associates with Pyk2
[15], a tyrosine kinase that has been implicated in inte-
grin-mediated signaling [16]. These results are consistent
with inhibition of adhesion through recruitment of SHP-1
by tyrosine-phosphorylated ITIM-containing receptors
such as KIR. ITIMs have been found in many receptors
that are expressed in a variety of cell types [1]. All
hematopoeitic cells express ITIM-containing receptors,
many of which have no known ligand or function [17]. Our
results suggest that ITIM-bearing receptors may act as
modulators of adhesion in order to regulate important cel-
lular functions such as cell polarization, migration, or
detachment from surrounding cells.
Materials and methods
YTS and YTS-2DL1 cells [2] were obtained from G. Cohen (Massa-
chusetts General Hospital, Boston). YTS-2DL1–SHP-1 and YTS-
2DL1–SHP-1(RM) cells were produced as described [2]. The arginine
at position 459 in SHP-1 was changed to a methionine by site-directed
mutagenesis in order to produce mutant SHP-1(RM), which has greatly
decreased affinity for substrate and catalytic activity [13]. A KIR2DL1
cDNA was truncated just upstream of the sequence encoding the first
ITIM and ligated in frame to the third codon of a SHP-1 cDNA. The
resulting 2DL1–SHP-1 chimera contains KIR2DL1 with the first 33
amino acids of its cytoplasmic tail spliced to the SHP-1 molecule with
its two SH2 domains. HLA-Cw3, -Cw4, -Cw8, and -Cw15 transfec-
tants of 721.221 were obtained from J. Gumperz and P. Parham (Stan-
ford University). Antibody EB6 (IgG1, reactive with KIR2DL1) was from
Immunotech, anti-LFA-1 (IgG1, specific for CD11a) from Upstate
Biotechnology, CD28.2 (IgG1, specific for CD28) from PharMingen,
MOPC21 (control IgG1) and MOPC104E (control IgM) from Sigma.
HP-3E4, an IgM reactive with KIR2DL1 [18], was a gift from M. López-
Botet (Hospital de la Princesa, Madrid, Spain). Secondary fluorescein
isothiocyanate (FITC)- and phycoerythrin (PE)-coupled anti-mouse IgG
or IgM were from Jackson Research Laboratories. CTLA4-Ig was from
Pharmingen. PP1 was from Biomol Research laboratories.
Conjugate assay
721.221 and YTS cells were labeled with the fluorescent cell linker
compounds PKH26-GL (red) and PKH67-GL (green), respectively
(Sigma), in 10 mM dye at 5 ´ 106 cells/ml for 5 min at room tempera-
ture. The dye staining reaction was stopped by addition of two volumes
of fetal bovine serum. The cells were diluted further in two volumes of
medium, washed three times, and rested for at least 1 h at 37°C. Cells
were resuspended in cold medium containing 5% FBS. 1 ´ 105 effec-
tor and 2 ´ 105 target cells were mixed in a final volume of 200 ml in
5 ml round-bottom tubes (Falcon 2052), mixed by gentle vortexing, and
centrifuged at 4°C for 3 min at 300 rpm (25 ´ g). Samples were placed
in a 37°C water bath for various times. Cells were resuspended by vor-
texing, fixed by adding 1 ml of ice-cold 0.5% paraformaldehyde in
DPBS, and promptly analyzed on a FACscan (Becton-Dickinson).
Results are expressed as percentage of NK cells that formed conju-
gates with target cells as calculated by the ratio of two-color events to
total effector cell events. For antibody inhibition experiments, NK cells
were pre-incubated for 15 min at 4°C in twice the final concentration of
antibody prior to the addition of target cells. CTLA-4–Ig was incubated
with target cells for 15 min at 4°C prior to the addition of NK cells. For
inhibition with PP1, NK cells were pre-incubated for 30 min at 37°C in
the indicated concentration of inhibitor. Target cell lysis was measured
in a standard 51chromium release assay as described [4].
Supplementary material
Supplementary material including data on the YTS-2DL1 cell; on conju-
gate formation with 221-Cw15 and -Cw8 cells; on temperature depen-
dence of conjugate formation; and on adhesion mediated by the
KIR2DL1–HLA-Cw4 interaction, and additional methodological details
is available at http://current-biology.com/supmat/supmatin.htm.
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